Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0037116 (
silicosis
)
1,822
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lysozyme in serum (
LZM
, EC 3.2.1.17) was assayed in 135 male patients with
silicosis
. Twenty-eight of the patients had controls matched for exposure to silica dust, age and sex but with no radiographical signs of
silicosis
. A reference group without exposure to silica dust was composed of 34 lumberjacks. The mean concentration of serum
LZM
was higher in
silicosis
patients (7.8 +/- 2.8 mg/l, n = 28) than in the controls exposed to silica (6.0 +/- 1.7 mg/l, p less than 0.05), or in the lumberjacks (5.7 +/- 2.1 mg/l, p less than 0.01). There was an association between serum
LZM
concentration and radiographic severity of
silicosis
, and on a group basis an association of serum
LZM
concentration with the progression of
silicosis
. In the multivariate regression analysis the highest regression coefficients were found for progression of small opacities as well as patient age. The results suggest that the elevation of
LZM
concentration is associated with the progression of the disease.
...
PMID:Serum lysozyme concentration in silicosis patients and workers exposed to silica dust. 648 83